InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Huang Michael F.. Director active across 1 company, notably Soleno Therapeutics INC. Aggregated, 7 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €196k. History available since 17 July 2024. The latest transaction was disclosed on 27 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Huang Michael F. is a declarant linked to Soleno Therapeutics INC, where he is Sr. VP of Clinical Development. He has 6 filings in total. In the 6 most recent filings we hold, covering the period from 2024-07-19 to 2026-03-31, sales total 196484 EUR and the modal transaction nature is Sale.